Vous êtes sur la page 1sur 3

REFERINȚE BIBLIOGRAFICE

[1] Cancerul de testiculi-Lucian Miron; pref. de Giovanni Rosti-Iași; Polirom, 1999,


248 de pagini, 24 cm (Bios.Științe medicale).
[2] *** http://www.mymed.ro/testiculele.html
[3] Einhorn L.H., Richie P.J., Shipley W.V., "Cancer of testis" , in De Vita V.T,
Hellman S., Rosenberg S.A., (ed) : Cancer principles and practice of oncology, Philadelphia,
J.B. Lippincott Comp., 4th ed., 1993,1126-1151.
[4] Horwich A., "Testicular germ cell tumors: an introduction overview", in
Testicular cancer-investigation and management, second ed. Horowich A.(ed.) Chapman &
Hall Med. London, 1996, 1-14.
[5] Bonadonna G., "Neoplasie del testicolo" in Manuale di Oncologia Medica, 4 ed.
G. Bonadonna, D.C. Robustelli (eds), Mason, Milano ,770-781.
[6] Davis J.M., Testicular cancer in England and Wales: Some epidemiological
aspects, Lacet, 1981, 928-938.
[7] Pottern L.M., Brown L.M., Susan Devesa, "Epidemiology and pathogenesis of
testicular cancer", in Ernoff M.S., Heaneey J.A., Peschel R.E. (eds), Testicular and penile
cancer, Blackwell Scie. Oxford, 1998, 1-10.
[8] Loehrer P.J., Thomas E.A., Pollack P., "Testicular cancer", in Pazdur R., Coio
L.R., Hoskins W.J., Wayman L.D. (eds), Cancer management – A multidisciplinary approach,
PRR-Hantings, 1996, 401-416.
[9] Oosterhuis J.W., Andrews J.W., "Differetation in germ cell tumors", in Testicular
Cancer: Investigation and management, second ed; A. Horowich (ed), Chapman and Hall
Medical, London 1996,61-72.
[10] Bosl G.L., Ilson D.H., Rodriguesz E., Motzer R.J., Reuter V.E., Chaganti R.S.,
Clinical relevance of the i (12p) marker chromosome in germ cell tumors, J.Nat. Instit.
1994,86,5,349-356.
[11] Dr. Giovanni Rosti, Clinica de Oncologie Medicală Ospedale Civile Ravenna,
Italia.
[12]***http://jurnaluldechirurgie.ro/jurnal/docs/jurnal410/art%2015_vol%206_2010_
nr%204.pdf
[13] Bosl J.G., Bajorin D.F., Sheinfeld J., Mozer J.R., "Cancer of the testis", in De
Vita V.T Hellman S., Rosenberg S.A. (eds), Cancer principles and practice of oncology,
Philadelphia, Lippincott Raven Publishers, 5th ed., 1997, 1397-1425.
[14] Schned A.R.,"The patology of germ-cell cancers of the testies", in Ernstoff M.S.,
Heaney J.A., Peschel R.E.(eds), Testicular and penile cancer, Blackwell Science, Oxford,
1998, 11-39.
[15] Maier J.G., Sulak M.H., "Radiation therapy in malignant testis tumors", Part III,
Carcinoma Cancer, 1973, 32, 1217-1226.
[16] Skakkebaek N.E., Possible carcinoma "in situ" of the testis, Lancet, 1972, ii:
516-517.
[17] Montie J.E “Testicular cancer.Diagnosis and staging.” Semin. Urol., 1984, 2,
194-201.
[18] Proca E., ”Tumorile testiculare”, în Proca E.(ed.), Tratat de patologie
chirurgicală, vol VIII,Ed. Medicală, București, 1984, 294-330.)
[19] Husband J.E., Peckham M.J., Mac Donald J.S., Hendry W.F., The role of
computed tomography in the management of testicular teratoma, Clin. Radol., 1979, 30, 243-
252.
[20] Richie J.P., Neoplasms of the testis, in: Walsh P.C., Retik A.B., Stamey
T.A.,Vaughan E.D. (eds), Cambell s urology, 6th ed., Philadelphia, Saunders, 1992.
[21] 5-Mason M.D.,”Tumors markers”, in Testicular cancer> Investigation and
management, Horovitz A., second ed., Chapman &Hall, 1996, 35-51.
[22] Mostofi F.K., Tumors markers and pathology of testicular tumors, Prog. Clin.
Biol. Res., 1994, 153, 69-87.
[23] Kohn J., The value of apparent half-life assay of alpha - 1 fetoprotein in the
management of testicular teratoma. Carcinoma Embrionic Proteins, vol II, Elsenier,
Biomedical Press, Amsterdam, 1979, 383-386.
[24] Mostofi F.K., Tumors markers and pathology of testicular tumors, Prog. Clin.
Biol. Res., 1994, 153, 69-87
[25] Pera M.F., Blasco-Lafite M.J., Mill S.J., Cultured stem cell from human
testicular teratomas the nature of embrional carcinoma and its comparison with two types of
yolk sac carcinoma, Int.J.Cancer, 1987, 40, 334-343.)
[26] Boden G.,Gibb R.,Radiotherapy and testicular neoplasms, Lancet, 1951, 2,2,
1195-1197.
[27] Peckmham M.J., Barett A., Mc. Elwain T.J., Hendry W.F., Raghavan D., Non-
seminoma germ cell tumors (malignant teratomas) of the testis, Br.J.Urol. 1981, 53, 162-172.
[28] Scheinfeld J., Bajorin D., Management of the postchemotherapy residual mass,
Urol. Clin. North Am., 1993, 20, 133-143.
[29] Bokemeyer C., Schmoll H.J., Choffsri P.J., Harstrick A., Bading M., Paliwoda
H., "Bilateral testicular tumors: prevalence and clinical implication", Eur.J.Cancer, 1993, 29
A, 874-876.
[30] Miron L., "Strategia terapeutică actuală în cancerele testiculare", Rev. Med.
Chir., 1995, vol. 99, 29-40.
[31] Motzer R.J., Bajorin D.F., Schwartz L.H., "Phase II trial of Paclitaxel shows
antitumor activity in patients with previously treated germ cell tumors", J.clin.Onco., 1994,
12, 2277-2283.
[32] *** http://www.infertilitate.ro/index.php?page=121&subpage=156
[33]***https://ro.pinterest.com/pin/create/button/?guid=aLgnsZ_b0NGZ&url=http%3
A%2F%2Fwww.bendo.ro%2Fboli-ale-testiculelor-si-cauze-de-infertilitate-
masculina%2F&media=http%3A%2F%2Fwww.bendo.ro%2Fwp-
content%2Fuploads%2F2011%2F05%2Fanatomie-
testicol.jpg&description=anatomie%20testicol